Cti Biopharma Corp
CTICDelisted Jun 26, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000891293
Cti Biopharma Corp was delisted on Jun 26, 2023; its insiders filed their last Form 4 on Jun 28, 2023; 133 institutions reported holding it in 13F filings for Q1 2023, worth $475.2M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Cti Biopharma Corp as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 133
- +15 vs. Q2 2022
- Shares held
- 97.7M
- +9.19M (+10.4%) vs. Q2 2022
- Total value
- $554.7M
- +$44.6M (+8.7%) vs. Q2 2022
- New holders
- 27
- 48 more added
- Sold out
- 12
- 44 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CTIC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 2 | $474.2K |
| Q1 2023 | 133 | $475.2M |
| Q4 2022 | 145 | $619.8M |
| Q3 2022 | 133 | $554.7M |
| Q2 2022 | 119 | $510.1M |
| Q1 2022 | 92 | $344.9M |
| Q4 2021 | 63 | $118.3M |
| Q3 2021 | 56 | $159.6M |
| Q2 2021 | 50 | $133.1M |
| Q1 2021 | 55 | $126.1M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Cti Biopharma Corp; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Susquehanna International Group, LLP | 643,992 | $3.75M | 0.01% | +411,568+177.1% | Added |
| Barclays PLC | 678,613 | $3.95M | 0.00% | +673,949+14,450.0% | Added |
| Ensign Peak Advisors, Inc | 706,277 | $4.11M | 0.01% | +557,186+373.7% | Added |
| Bank of America Corp | 715,063 | $4.16M | 0.00% | +457,780+177.9% | Added |
| Morgan Stanley | 726,105 | $4.22M | 0.00% | −144,991−16.6% | Reduced |
| Perceptive Advisors LLC | 735,165 | $4.28M | 0.12% | +735,165 | New |
| Northern Trust Corp | 804,519 | $4.68M | 0.00% | +49,100+6.5% | Added |
| Two Sigma Advisers, LP | 944,113 | $5.50M | 0.02% | −57,000−5.7% | Reduced |
| Sectoral Asset Management Inc | 968,300 | $5.64M | 1.11% | +968,300 | New |
| Silverarc Capital Management, LLC | 983,516 | $5.72M | 2.43% | −396,595−28.7% | Reduced |
| Citigroup Inc | 989,446 | $5.76M | 0.01% | +547,603+123.9% | Added |
| Rafferty Asset Management, LLC | 1,093,043 | $6.36M | 0.07% | +655,442+149.8% | Added |
| JPMorgan Chase & Co | 1,139,110 | $6.63M | 0.00% | −32,664−2.8% | Reduced |
| Parkman Healthcare Partners LLC | 1,210,145 | $7.04M | 2.00% | +159,098+15.1% | Added |
| Verition Fund Management LLC | 1,241,311 | $7.22M | 0.10% | −43,014−3.3% | Reduced |
| Schonfeld Strategic Advisors LLC | 1,329,476 | $7.74M | 0.07% | +481,776+56.8% | Added |
| Nuveen Asset Management, LLC | 1,353,509 | $7.88M | 0.00% | −396,684−22.7% | Reduced |
| Goldman Sachs Group Inc | 1,535,544 | $8.94M | 0.00% | +887,948+137.1% | Added |
| Voloridge Investment Management, LLC | 1,580,934 | $9.20M | 0.05% | +753,143+91.0% | Added |
| Driehaus Capital Management LLC | 1,633,541 | $9.51M | 0.14% | +1,633,541 | New |
| Geode Capital Management, LLC | 1,778,969 | $10.4M | 0.00% | +190,422+12.0% | Added |
| Ghost Tree Capital, LLC | 2,000,000 | $11.6M | 4.75% | +1,200,000+150.0% | Added |
| Lion Point Capital, LP | 4,389,546 | $11.7M | 4.72% | −1,100,000−20.0% | Reduced |
| Wellington Management Group LLP | 2,819,663 | $16.4M | 0.00% | +1,286,193+83.9% | Added |
| Sofinnova Investments, Inc. | 3,612,376 | $21.0M | 1.34% | +907,866+33.6% | Added |
| NEA Management Company, LLC | 3,685,683 | $21.5M | 1.07% | −4,361,545−54.2% | Reduced |
| Bleichroeder LP | 3,943,730 | $23.0M | 4.79% | −5,000−0.1% | Reduced |
| Millennium Management LLC | 4,754,128 | $27.7M | 0.03% | +1,586,041+50.1% | Added |
| Vanguard Group Inc | 4,786,023 | $27.9M | 0.00% | +409,584+9.4% | Added |
| Stonepine Capital Management, LLC | 5,669,388 | $33.0M | 14.83% | +1,988,193+54.0% | Added |
| BlackRock Inc. | 6,598,773 | $38.4M | 0.00% | +707,804+12.0% | Added |
| BVF Inc | 8,813,021 | $51.3M | 2.12% | −116,669−1.3% | Reduced |
| State Street Corp | 13,742,554 | $80.0M | 0.01% | +3,893,026+39.5% | Added |
| Fairmount Funds Management LLC | 0 | $0 | 0.00% | −2,245,891−100.0% | Sold out |
| RTW Investments, LP | 0 | $0 | 0.00% | −471,630−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −102,333−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −97,805−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −52,310−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −55,530−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −52,200−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −29,000−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −14,669−100.0% | Sold out |
| BDO Wealth Advisors, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| Sound Income Strategies, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Dorsey Wright & Associates | – | – | – | – | Not filed |